Syndax Pharmaceuticals Inc Development Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 12 to Clinical Trial Agreement between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2020
Amendment No. 11 to Clinical Trial Agreement between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2019
Amendment No. 8 to Clinical Trial Agreement between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2017
Amendment No. 6 to Clinical Trial Agreement between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
Amendment No. 5 to Clinical Trial Agreement between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
Amendment No. 4 to Clinical Trial Agreement E2112 between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
Amendment No. 3 to Clinical Trial Agreement between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
Amendment No. 2 to Clinical Trial Agreement E2112 between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016
Amendment No. 1 to Clinical Trial Agreement between ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals, Inc.
Development Agreements
Syndax Pharmaceuticals Inc
Biotechnology
2016